Therapeutic Areas

Multi-therapeutic reach, built on neurology depth

GTC leads with established relationships, patient access and active study opportunities. Neurology & CNS is the proven foundation; the broader brand expands as physician relationships and study opportunities develop.

Neurology & CNS

Area detail →

GTC’s proven foundation. Deep experience recruiting for complex central-nervous-system and neuromuscular studies, including rare and ultra-rare indications.

  • Alzheimer’s disease
  • Multiple sclerosis
  • Myasthenia gravis
  • Parkinson’s disease
  • Huntington’s disease
  • Amyotrophic lateral sclerosis (ALS)
  • CIDP and multifocal motor neuropathy
  • Stiff-person syndrome
  • Other neurologic conditions

Pain Management

Area detail →

Physician and healthcare partnerships built around interventional and medical pain practices for both pharmaceutical and device studies.

  • Chronic pain
  • Low-back pain
  • Neuropathic pain
  • Interventional pain
  • Pharmaceutical and device studies

Orthopedics & Spine

Area detail →

Access to degenerative spine and musculoskeletal populations through community orthopedic and spine specialists.

  • Degenerative spine conditions
  • Osteoarthritis
  • Musculoskeletal conditions
  • Surgical / device studies
  • Biologics

Cardiovascular

Area detail →

Relationships with cardiology and primary-care networks managing large at-risk populations for pharmaceutical and device research.

  • Hypertension
  • Atherosclerotic disease
  • Peripheral artery disease (PAD)
  • Heart failure / cardiovascular disease
  • Pharmaceutical and device studies

Diabetes

Area detail →

Relationships with endocrinology and primary-care networks managing large diabetes populations — with a natural tie to GTC’s neurology depth for diabetic neuropathy studies.

  • Type 2 diabetes
  • Type 1 diabetes
  • Diabetic kidney disease
  • Diabetic peripheral neuropathy
  • Diabetic retinopathy
  • Pharmaceutical and device studies

Emerging Therapeutic Areas

Area detail →

Additional therapeutic areas are evaluated based on the strength of GTC’s physician, healthcare and patient-access relationships — so new specialties can be added as opportunities develop.

  • Evaluated against active study opportunities
  • Driven by established physician relationships
  • Prioritized by patient-access strength

Don't see your indication?

We evaluate additional therapeutic areas based on the strength of our physician, healthcare and patient-access relationships. Tell us about the study and we'll tell you candidly whether GTC can help.

Discuss a study

Ready to accelerate enrollment?

Partner with Global Trial Consultants to expand access to innovative therapies across therapeutic areas.